News

Jede zehnte Person in der Schweiz hat schon einmal Angebote einer Neobank genutzt, wie der aktuelle Swiss Payment Monitor der Universität St.Gallen und der ZHAW zeigt. Ermutigende Resultate ergab die Studie auch für das Schweizer Startup Neon.

Swiss travel-tech company The Trip Boutique has closed its first financing round. Among the investors is Samih Sawiris (Orascom), Elisabeth Stevens (former Booking.com director), Peter H. Müller (business angel) and Susanna Lemann (Roger Federer Foundation).

Hemotune AG, a spin-off from ETH Zurich founded in 2017 and currently incubated at Wyss Zurich, today announced the closing of a CHF 5.1 million Series A to advance the development of HemoSystem, a breakthrough blood purification platform based on nanoengineered magnetic beads.

Die seit Mitte 2016 operative Direct Lending-Plattform swisspeers vermittelt Fremdkapital an Schweizer KMU. Jetzt hat sie selber Pflichtwandeldarlehen über gut eine halbe Million Franken ausgegeben.

BOND Mobility has acquired the micromobility data fusion and predictive analytics solution from ETH Zurich spin-off Roll2Go. Co-founder Lukas Ballo will join BOND Mobility as Head of Data Analytics.

The Swiss Government has signed a deal with Molecular Partners securing the rights to purchase doses of its first anti COVID-19 program. Swiss Government will pay a reservation fee in the high single digit millions Swiss Francs for the right to purchase up to 3.2 million doses of anti-COVID-19 DARPin candidate, MP0420, for both therapeutic and potential...

Das Wädenswiler Startup MIRAI FOODS hat als erstes Schweizer Unternehmen Rindfleisch im Labor gezüchtet. Das Ergebnis sind vier Miniburger mit echtem Fleisch aus tierischen Zellen. Erste Investorinnen und Investoren haben die Burger schon verkostet.

The first edition of the Luxury Innovation award is coming to the end. The jury has nominated eight finalists that will present their innovations during the award ceremony on 27 August in Geneva. Among the finalists are five Swiss startups in four categories.

Several top management positions in different startups are now occupied – from Chief Executive Officer at NBE Therapeutics to Chief Medical Officer at Cellestia Biotech. Two startups have also welcomed a new Chief Financial Officer.

The U.S. Food and Drug Administration (FDA) has accepted Biogen’s Biologics License Application and granted priority review for the approval of aducanumab as a treatment for Alzheimer’s disease. If approved, aducanumab would be the first treatment with the potential to meaningfully change the course of Alzheimer’s disease.